Page 39 - 71_02

VOL. 71 (2), 283-319, 2005 PURINERGIC SIGNALLING: THERAPEUTIC POTENTIAL

(20) RYTEN, M., YANG, S. Y., DUNN, P. M., GOLDSPINK, G., AND BURNSTOCK, G. (2004):
(21) FASEB J. 18: 1404-1406.
(22) UNWIN, R. J., BAILEY, M. A., AND BURNSTOCK, G. (2003): News Physiol. Sci. 0 18:
(23) 237-241.
VONEND, O., TURNER, C., CHAN, C. M., LOESCH, A., DELL’ANNA, G. C., SRAI, S. K.,
(24) BURNSTOCK, G., AND UNWIN, R. (2004): Kidney Int. 66: 157-166.
(25) BURNSTOCK, G. (2003): Purinergic receptors in the nervous system. In
(26) Schwiebert, E. M., editor. Current Topics in Membranes, Vol. 54. Purinergic
(27) Receptors and Signalling, Academic Press, San Diego, pp. 307-368.
(28) FUJII, S., KATO, H., AND KURODA, Y. (2002): Neuroscience 113: 617-628.
(29) OGATA, T., CHUAI, M., MORINO, T., YAMAMOTO, H., NAKAMURA, Y., AND SCHUBERT,
(30) P. (2003): Brain Res. 981: 174-183.
TSUDA, M., SHIGEMOTO-MOGAMI, Y., KOIZUMI, S., MIZOKOSHI, A., KOHSAKA, S.,
(31) SALTER, M. W., AND INOUE, K. (2003): Nature 424: 778-783.
(32) ABRAHAM, E. H., SALIKHOVA, A. Y., AND RAPAPORT, E. (2003): Current Topics in
(33) Membranes 54: 415-452.
(34) CALVERT, R. C., SHABBIR, M., BANKS, F., THOMPSON, C. S., MIKHAILIDIS, D. P.,
MORGAN, R., AND BURNSTOCK, G. (2004): Anticancer Research 24: 2853-2859.
(35) WHITE, N., RYTEN, M., CLAYTON, E., BUTLER, P. AND BURNSTOCK, G. (2005):
(36) Cancer Letters (on-line).
(37) GREIG, A. V. H., LINGE, C., HEALY, V., LIM, P., CLAYTON, E., RUSTIN, M. H.,
(38) MCGROUTHER, D. A., AND BURNSTOCK, G. (2003): J. Invest. Dermatol. 121: 315-
(39) 327.
(40) BURNSTOCK, G. (1996): Lancet 347: 1604-1605.
VLASKOVSKA, M., KASAKOV, L., RONG, W., BODIN, P., BARDINI, M., COCKAYNE, D. A.,
(41) FORD, A. P. D. W., AND BURNSTOCK, G. (2001): J. Neurosci. 21: 5670-5677.
(42) RONG, W. AND BURNSTOCK, G. (2004): Neuropharmacology 47: 1093-1101.
MCGARAUGHTY, S., WISMER, C. T., ZHU, C. Z., MIKUSA, J., HONORE, P., CHU, K. L.,
LEE, C. H., FALTYNEK, C. R., AND JARVIS, M. F. (2003): Br. J. Pharmacol. 140:
1381-1388.
YERXA, B. R. (2001): Drug Dev. Res. 52: 196-201.
ADRIAENSEN, D. AND TIMMERMANS, J. P. (2004): Curr. Opin. Pharmacol. 4: 207-
214.
PINTOR, J., PERAL, A., PELÁEZ, T., CARRACEDO, G., BAUTISTA, A., AND HOYLE, C. H.
(2003). Drug Dev. Res. 59: 136-145.
SUETA, T., PAKI, B., EVERETT, A. W., AND ROBERTSON, D. (2003): Hear. Res. 183:
97-108.
GAYLE, S. AND BURNSTOCK, G. (2004): Cell Tissue Res. (on-line).
BURNSTOCK, G. (2001): Purinergic signalling in lower urinary tract. In
Abbracchio, M. P. and Williams, M., editors. Handbook of Experimental
Pharmacology, Volume 151/I. Purinergic and Pyrimidinergic Signalling I -
Molecular, Nervous and Urinogenitary System Function, Springer-Verlag,
Berlin, pp. 423-515.
ANDERSSON, K. E. AND HEDLUND, P. (2002): Urology 60: 13-20.
GLASS, R., BARDINI, M., ROBSON, T., AND BURNSTOCK, G. (2001): Cells Tissues Org.
169: 377-387.

319